Results 191 to 200 of about 1,437,842 (362)

Self‐Assembling Multi‐Antigen T Cell Hybridizers for Precision Immunotherapy of Multiple Myeloma

open access: yesAdvanced Healthcare Materials, EarlyView.
A novel modular T‐cell engager platform, MATCH, is developed for personalized multiple myeloma therapy. MATCH uses complementary oligonucleotide‐linked Fab’ fragments to enable flexible targeting of MM antigens and controlled T‐cell activation. The system shows potent, antigen‐specific cytotoxicity in vitro and in vivo, highlighting its potential for ...
Shannuo Li   +8 more
wiley   +1 more source

A Diagnosis in Vein [PDF]

open access: yesThe American Journal of Medicine, 2010
Marie Gerhard-Herman   +2 more
openaire   +3 more sources

The French Experience of Pharmacists and CAR T-Cells: A Study of the French Society of Oncology Pharmacy (SFPO). [PDF]

open access: yesHematol Oncol
Schwiertz V   +19 more
europepmc   +1 more source

Photoactivated Proximity Protein Labeling Reveals Enhanced Tumor Retention of a D‐Peptide‐Ruthenium Prodrug Conjugate

open access: yesAdvanced Healthcare Materials, EarlyView.
Six stereoisomeric ruthenium‐peptide conjugates were synthesized and characterized, which showed high potential in photoactivated chemotherapy (PACT) and proximity protein labeling. Abstract Amino acid chirality is known to influence the biological properties of peptide‐containing prodrugs.
Liyan Zhang   +7 more
wiley   +1 more source

Varicose Veins

open access: yesAsian Journal of Surgery, 2003
openaire   +2 more sources

Vein is Best [PDF]

open access: yesEuropean Journal of Vascular and Endovascular Surgery, 2020
openaire   +2 more sources

Decreased portal vein velocity is predictive of the development of portal vein thrombosis: A matched case‐control study

open access: yesLiver international (Print), 2018
J. Stine   +7 more
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy